|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-12-16
|
|
pubmed:abstractText |
To describe the pharmacokinetic-pharmacodynamic modelling of the psychomotor and mnesic effects of a single 2 mg oral dose of lorazepam in healthy volunteers.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0306-5251
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
510-2
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:10583020-Amnesia, Anterograde,
pubmed-meshheading:10583020-Anti-Anxiety Agents,
pubmed-meshheading:10583020-Cross-Over Studies,
pubmed-meshheading:10583020-Double-Blind Method,
pubmed-meshheading:10583020-Humans,
pubmed-meshheading:10583020-Lorazepam,
pubmed-meshheading:10583020-Memory,
pubmed-meshheading:10583020-Memory, Short-Term,
pubmed-meshheading:10583020-Time Factors
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Pharmacokinetic-pharmacodynamic analysis of mnesic effects of lorazepam in healthy volunteers.
|
|
pubmed:affiliation |
Fédération de Pharmacologie Médicale et Clinique et Pharmacocinétique, Marseille, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
